Eyestem, a Bengaluru-based cell therapy company, has raised funding from Endiya Partners, a venture capital fund that focuses on investing in firms in technology, healthcare and life sciences.

— Hindu Business Line

Argus Partners advised Eyestem Research, led by a team of partners Vinod Joseph and Suchita Ambadipudi along with associates Smriti Tripathi, Protiti Basu, Pranav Pillai and Anurag Prasad.

2021-05-26

Deal value: Confidential

{incomplete}